Cell and Gene Therapy Containment
Posted: 18 December 2024 | West Pharmaceutical Services | No comments yet
Cell and gene therapies (CGTs) typically target genetic diseases or diseases with very high unmet needs and limited existing therapeutic options. Therefore, quickly getting these life-altering therapies to the market is critical for patients. This white paper will review some hurdles that can slow your time to market and proven West solutions to help you mitigate risk and simplify the journey.
Related content from this organisation
Related topics
Cell culture automation, Cell-Based Assays for Screening, Drug Discovery, Gene therapy